Purification of recombinant high molecular weight two-partner secretion proteins from Escherichia coli.
This protocol describes the purification of a recombinant high molecular weight (HMW) two-partner secretion exoprotein (generically referred to as TpsA proteins) from Escherichia coli using methods developed recently to obtain highly purified flagellin-free recombinant EtpA (rEtpA) glycoprotein. The protocol addresses problems frequently encountered with the expression of these HMW proteins, namely plasmid instability and protein degradation, as well as a recently recognized issue of flagellin contamination. Briefly, the TpsA protein of interest is expressed with its outer membrane transporter (TpsB) protein in a flagellin-minus recombinant E. coli background. Culture supernatants are collected, concentrated through high molecular weight cutoff filters, followed by purification by size exclusion column chromatography. Details are included for the expression of HMW TpsA glycoproteins as polyhistidine-tagged molecules, which can be further purified by metal affinity chromatography (MAC). Using this protocol, it is possible to obtain highly purified microgram-milligram quantities of the TpsA protein of interest within 2-3 days.
Fleckenstein
James M
JM
Department of Veterans Affairs Medical Center Research (151), Memphis, Tennessee, USA. jflecke1@tennessee.edu
Roy
Koushik
K
D001709:Biotechnology / Q000379:methods*; D004926:Escherichia coli / Q000235:genetics / Q000502:physiology*; D029968:Escherichia coli Proteins / Q000302:isolation & purification* / Q000378:metabolism; D008970:Molecular Weight; D010957:Plasmids / Q000235:genetics; D011994:Recombinant Proteins / Q000302:isolation & purification* / Q000378:metabolism
D029968:Escherichia coli Proteins; D011994:Recombinant Proteins
Nature. 1970 Aug 15;227(5259):680-5
5432063
Biotechniques. 2001 Aug;31(2):322-3, 326-8
11515368
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 Apr 1;61(Pt 4):448-50
16511066
Proteomics. 2006 Sep;6 Suppl 2:61-4
17031800
Mol Microbiol. 2006 Jul;61(2):470-83
16771846
Nature. 2001 Apr 26;410(6832):1099-103
11323673
Infect Immun. 2006 Apr;74(4):2245-58
16552055
Res Microbiol. 2007 Oct-Nov;158(8-9):631-7
17913468
Mol Microbiol. 2003 May;48(3):737-51
12694618
Infect Immun. 2001 Oct;69(10):6201-8
11553561
Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4
388439
N Engl J Med. 2005 Oct 13;353(15):1555-63
16221778
Infect Immun. 2008 May;76(5):2106-12
18285493
Mol Microbiol. 2001 Apr;40(2):306-13
11309114
Nature. 2009 Jan 29;457(7229):594-8
19060885
Mol Microbiol. 2000 Apr;36(1):55-67
10760163
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):14819-24
11752429
Biopolymers. 2008 May;89(5):420-7
18189304
J Bacteriol. 1978 Jun;134(3):1141-56
149110
Nat Rev Microbiol. 2005 Mar;3(3):225-37
15738950
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6194-9
15079085
Mol Microbiol. 1998 Feb;27(3):617-30
9489673
J Chromatogr B Biomed Sci Appl. 2000 Jan 14;737(1-2):13-23
10681037
Trends Microbiol. 2007 Nov;15(11):508-15
17988872
Infect Immun. 1994 Aug;62(8):3320-8
8039903
FEMS Microbiol Lett. 1991 Feb;78(1):59-64
2032624
J Bacteriol. 1995 Jul;177(14):4121-30
7608087
N Engl J Med. 1996 Feb 8;334(6):341-8
8538704